loading...| Preferred Name |
obeticholic acid |
| Synonyms |
DSP-1747 |
| ID |
http://purl.bioontology.org/ontology/MESH/C464660 |
| altLabel |
DSP-1747 INT 747 6ECDCA 6-ECDCA 6-ethylchenodeoxycholic acid Ocaliva INT747 DSP1747 6alpha-ethyl-3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid INT-747 6-ethyl-3,7-dihydroxycholan-24-oic acid cholan-24-oic acid, 6-ethyl-3,7-dihydroxy-, (3alpha,5beta,6alpha,7alpha)- 6-ethyl chenodeoxycholic acid 6alpha-ethyl-chenodeoxycholic acid |
| cui |
C4271005 C1143018 C2830015 C4307728 |
| Has mapping qualifier | |
| HM |
D002635/Q000031 |
| Inverse of RB |
0462Z4S4OZ |
| LT |
TRD |
| Mapped to | |
| MDA |
20020831 |
| MeSH Frequency |
151 |
| MMR |
20161006 |
| notation |
C464660 |
| prefLabel |
obeticholic acid |
| SC |
1 |
| Scope Statement |
A farnesoid X receptor agonist and anticholestatic agent that is used in the treatment of chronic liver diseases; structure in first source. |
| SRC |
J Med Chem 2002 Aug 15;45(17):3569-72 |
| TERMUI |
T000908619 T000908616 T000870768 T816533 T518064 T816531 T816532 T816535 T000908862 T000908617 T518065 T518066 T000870799 T816534 T000870767 |
| TH |
NLM (2017) FDA SRS (2017) USAN (19XX) NLM (2002) NLM (2014) NLM (2012) INN (19XX) |
| tui |
T109 T121 |